Abstract | UNLABELLED: CONCLUSION:
|
Authors | A Avilés, J Halabe |
Journal | Cancer biotherapy & radiopharmaceuticals
(Cancer Biother Radiopharm)
Vol. 14
Issue 5
Pg. 349-52
(Oct 1999)
ISSN: 1084-9785 [Print] United States |
PMID | 10850319
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Anti-HIV Agents
- HIV Protease Inhibitors
- Bleomycin
- Lamivudine
- Zidovudine
- Vincristine
- Indinavir
- Granulocyte-Macrophage Colony-Stimulating Factor
- Cyclophosphamide
- Mitoxantrone
|
Topics |
- Acquired Immunodeficiency Syndrome
(drug therapy)
- Adult
- Anti-HIV Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Bleomycin
(administration & dosage)
- Cyclophosphamide
(administration & dosage)
- Disease-Free Survival
- Drug Therapy, Combination
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor
(therapeutic use)
- HIV Protease Inhibitors
(therapeutic use)
- Humans
- Indinavir
(therapeutic use)
- Lamivudine
(therapeutic use)
- Lymphoma, AIDS-Related
(drug therapy, mortality)
- Male
- Middle Aged
- Mitoxantrone
(administration & dosage)
- Prognosis
- Survival Rate
- Vincristine
(administration & dosage)
- Zidovudine
(therapeutic use)
|